Affimed Plunges After Drug Program Put On Hold Following Patient Death

In morning trading, shares of Affimed declined nearly 30% to $3.39.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.